Mohammadi, Mahmoud http://orcid.org/0000-0003-2775-5019
Jansen-Werkhoven, Thekla M.
Ijzerman, Nikki S.
den Hollander, Dide
Bleckman, Roos F.
Oosten, Astrid W.
Desar, Ingrid M. E.
Reyners, An K. L.
Steeghs, Neeltje
Gelderblom, Hans
Funding for this research was provided by:
Deciphera Pharmaceuticals (4EE9EEC-7F19-484D-86A4-646CFE0950A5)
Novartis (3017/13)
Pfizer Pharmaceuticals (WI189378)
Bayer (2014-MED-12005)
Article History
Accepted: 18 October 2022
First Online: 14 November 2022
Declarations
:
: No external funding was used in the analysis and preparation of this manuscript. An unrestricted research grant for the Dutch GIST Registry to NKI is received from Novartis (3017/13), Pfizer (WI189378), Bayer (2014-MED-12005), and Deciphera (4EE9EEC-7F19-484D-86A4-646CFE0950A5). These funding sources did not have any involvement in conducting this research.
: Mahmoud Mohammadi, Thekla M. Jansen-Werkhoven , Nikki S. IJzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, Ingrid M.E. Desar, An K.L. Reyners, Neeltje Steeghs and Hans Gelderblom declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: The local Medical Ethics Review Committee of LUMC confirmed that the Medical Research Involving Human Subjects Act did not apply for this study (registration no. G20.003).
: Not applicable.
: Not applicable.
: The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: MM: Conceptualization, Formal analysis, Writing—Original Draft, Writing—Review & Editing TMJ-W: Software, Investigation NSI: Investigation, Writing—Review & Editing DH: Investigation, Writing—Review & Editing RFB: Investigation, Writing—Review & Editing AWO: Writing—Review & Editing, IMED: Writing—Review & Editing, AKLR: Writing—Review & Editing, NS: Methodology, Writing—Review & Editing HG: Conceptualization, Methodology, Supervision.